AC Immune Q4 EPS $(0.17) Beats $(0.19) Estimate, Sales $422.914K

AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 7.89 percent. This is a 2.78 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $422.914 thousand which missed the analyst consensus estimate of $2.300 million by 81.61 percent. This is a 67.37 percent decrease over sales of $1.296 million the same period last year.